Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bitfarms Ltd. - BITF
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solaris Energy Infrastructure, Inc. - SEI
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KinderCare Learning Companies, Inc. - KLC
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - DDD
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action Lawsuit and Upcoming Deadlines - PPTA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in enCore Energy Corp. of Class Action Lawsuit and Upcoming Deadlines - EU
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Skyworks Solutions, Inc. of Class Action Lawsuit and Upcoming Deadlines - SWKS
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Lab USA, Inc. of Class Action Lawsuit and Upcoming Deadlines - RKLB
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Atkore Inc of Class Action Lawsuit and Upcoming Deadlines - ATKR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Constellation Brands, Inc of Class Action Lawsuit and Upcoming Deadlines - STZ
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Trade Desk of Class Action Lawsuit and Upcoming Deadlines - TTD
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Edison International of Class Action Lawsuit and Upcoming Deadlines - EIX
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Venture Global, Inc. of Class Action Lawsuit and Upcoming Deadlines - VG
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against SoundHound AI, Inc. and Certain Officers – SOUN
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FMC Corporation of Class Action Lawsuit and Upcoming Deadlines - FMC
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mullen Automotive, Inc. of Class Action Lawsuit and Upcoming Deadlines - MULN
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ICON Public Limited Company of Class Action Lawsuit and Upcoming Deadlines - ICLR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Monolithic Power Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - MPWR
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against e.l.f. Beauty, Inc. and Certain Officers – ELF
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Alarum Technologies Ltd. and Certain Officers – ALAR
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Elastic N.V. and Certain Officers – ESTC
-
Freshworks to Announce First Quarter 2025 Financial Results on April 29, 2025
-
Fixing of Coupon Rates - Nykredit Realkredit A/S
-
Jeffs’ Brands Finalizes Android Version of AI-Based Pest Control App- Ready for Google Play Submission
-
Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting
-
Iceland Seafood International hf: Bond Exchange Offer Result
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
-
FTI Consulting to Release First Quarter 2025 Results and Host Conference Call
-
Richard Quesnel Acquires Securities of Consolidated Lithium Metals Inc.
-
Serve Robotics Saddles Up for Autonomous Delivery in Dallas-Fort Worth Via Uber Eats
-
MariMed’s Betty’s Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews
-
Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with
-
Jayud Global Logistics Issues Statement Regarding Market Activity
-
Top Kingwin Ltd’s Subsidiary Tiancheng Chuangxin Technology Announces its Plan to Launch Desktop Robot 1.0 – Redefining the Smart Office Companion
-
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
-
Aveanna Healthcare Holdings Announces Agreement to Acquire Thrive Skilled Pediatric Care


